Antiretroviral regimens in elderly patients

What should we focus on when selecting an antiretroviral regimen for an elderly patient?

Philippe Morlat, MD, PhD: The main thing will be, I repeat myself [see: Pending pharmacokinetic studies of antiretroviral drugs in the elderly], the problem of interactions. We have to avoid some antiretroviral drugs that have this problem of interacting with other drugs. We should not give them drugs that are boosted with components called cobicistat or ritonavir, which affect elimination of other drugs. We have to pay attention with these drugs. But even taking this into consideration, we can give them any antiretroviral therapy.